Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-18-000589

Options or other derivatives

  • Director acquired 95,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Farokhzad Omid · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-05-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +95,000 $12.02 2028-05-29 95,000 95,000 D
Loading xslF345X03/doc4_5435.xml…